Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1

Eur Heart J. 2019 Sep 21;40(36):3010-3012. doi: 10.1093/eurheartj/ehz650.
No abstract available

MeSH terms

  • Administration, Oral
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Decision Trees
  • Hemorrhage / chemically induced
  • Humans
  • Patient Preference
  • Practice Guidelines as Topic
  • Risk Assessment*
  • Stroke / prevention & control*

Substances

  • Anticoagulants